| @KimEtAl_2022_GastrointestinalPermeationEnhancers | 2025/06/08 - 10:51 | |
| @CatacutanEtAl_2024_MachineLearningPreclinical | 2025/01/30 - 12:01 | |
| @MaratheEtAl_2013_GlucagonlikePeptides1 | 2025/05/17 - 13:50 | |
| @KaplanIrvin_2015_LikelihoodNullEffects | 2025/05/10 - 14:54 | |
| @LiuEtAl_2017_ThirtyyearQuestRole | 2021/01/18 - 13:53 | |
| @Lopez-EspinozaEtAl_2021_EffectKetogenicDiet | 2025/04/26 - 19:31 | |
| Curso Biotech Investing | 2025/06/01 | |
| @SeoEtAl_2009_RequirementBardetBiedlSyndrome | 2025/04/20 - 20:26 | |
| @MartinEtAl_2014_RapidCytoplasmicMechanism | 2025/01/26 - 16:34 | |
| @Galicia-GarciaEtAl_2020_PathophysiologyType2 | 2025/05/16 - 16:18 | |
| @LauEtAl_2021_OnceweeklyCagrilintideWeight | 2025/06/30 - 16:04 | |
| @ShepardPluznick_2017_SavingSweetnessRenal | 2025/04/18 - 19:55 | |
| @WangEtAl_2013_IntraisletGlucagonSecretion | 2025/04/21 - 16:54 | |
| @OngEtAl_2023_GlobalRegionalNational | 2025/05/16 - 17:42 | |
| @Della-FloraNunesEtAl_2025_IncompleteRemyelinationTherapeutically | 2025/01/25 - 12:01 | |
| @WangEtAl_2025_BCL6CoordinatesMuscle | 2025/02/12 - 18:06 | |
| @CoassoloEtAl_2025_ProhormoneCleavagePredictiona | 2025/04/09 - 08:04 | |
| @HendershotEtAl_2025_OnceWeeklySemaglutideAdults | 2025/02/15 - 15:33 | |
| @BuckleyEtAl_2018_TranscellularStomachAbsorption | 2025/06/08 - 17:45 | |
| @KnudsenLau_2019_DiscoveryDevelopmentLiraglutide | 2025/05/23 - 13:54 | |
| @SinghEtAl_2025_TranscriptomeguidedGLP1Receptor | 2025/04/20 - 09:39 | |
| @LinEtAl_2016_GPR142ControlsTryptophanInduced | 2025/05/13 - 20:31 | |
| Fases de ensayos clínicos | 2025/05/30 | |
| @Brent_2012_MechanismsThyroidHormone | 2025/01/26 - 17:19 | |
| @GarveyEtAl_2025_CoadministeredCagrilintideSemaglutide | 2025/06/23 - 17:07 | |
| @LiuEtAl_2021_FunctionalSelectivityBiased | 2025/07/10 - 12:52 | |
| @CaumoLuzi_2004_FirstphaseInsulinSecretion | 2025/04/18 - 18:54 | |
| @GorboulevEtAl_2011_Na+dglucoseCotransporterSGLT1 | 2025/05/13 - 20:29 | |
| @LuEtAl_2024_Type2Diabetes | 2025/05/16 - 15:47 | |
| Some Tacit Knowledge in Biotech | 2025/06/10 | |
| @CraterEtAl_2024_EffectsCB1RInverse | 2025/07/11 - 12:52 | |
| @LundEtAl_2015_EvidenceExtrapancreaticGlucagon | 2025/04/21 - 16:49 | |
| @KruseEtAl_2021_DevelopmentCagrilintideLongActing | 2025/06/25 - 20:36 | |
| Biotech Investing 101 | 2025/05/25 | |
| Valoración Biotech @biotech2k1 | 2025/08/11 | |
| @UngerCherrington_2012_GlucagonocentricRestructuringDiabetes | 2025/04/21 - 16:51 | |
| @Meshberger_1990_InterpretationMichelangelosCreation | 2025/01/25 - 10:53 | |
| @ElbersEtAl_2016_ThyroidHormoneMimetics | 2025/01/25 - 19:31 | |
| @ChungEtAl_2017_TimeGlucosePeak | 2025/04/19 - 11:22 | |
| @ZhengEtAl_2024_GlucagonlikePeptide1Receptor | 2025/05/13 - 09:02 | |
| @GaisanoEtAl_2012_GlucagonSecretionSignaling | 2025/04/22 - 10:03 | |
| @ChoEtAl_2022_IsletPrimaryCilia | 2025/04/20 - 20:03 | |
| @AlbertsEtAl_2015_MolecularBiologyCell | 2021/11/18 - 16:05 | |
| @MichaelidesEtAl_2025_GeneTherapyChildren | 2025/02/22 - 18:19 | |